Avalon GloboCare CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday, Se...
September 03 2020 - 11:11AM
Avalon GloboCare Corp. (NASDAQ: AVCO) (Avalon or The Company), a
clinical-stage global developer of cell-based technologies and
therapeutics, today announced that Dr. David Jin, M.D., Ph.D.,
President and Chief Executive Officer of Avalon Globocare, will
participate on a virtual panel, entitled, “New Approaches to
COVID-19: Hidden Breakthroughs,” being held on Thursday, September
10, 2020 at 1:00 p.m. ET.
The virtual panel discussion will also include:
Tom Equels, CEO of AIM ImmunoTech Inc. (AIM); Jeff Wolf, CEO of
Heat Biologics, Inc. (HTBX); Dr. Jennifer Bath, CEO of
ImmunoPrecise Antibodies Ltd. (IPA.V, IPATF, TQB2) and Vered
Caplan, CEO of Orgenesis Inc. (ORGS).
The event brings together executives from
leading biopharmaceutical companies to discuss how their companies
are helping address the COVID-19 pandemic. The panel will be
moderated by broadcast journalist Christine Corrado of Proactive
Investors. Investors interested in attending the event can register
at:
https://zoom.us/webinar/register/8215990551540/WN_YFe8n6dQSm6mpgG3iWfF-w.
About Avalon GloboCare
Corp.Avalon GloboCare Corp. (NASDAQ: AVCO) is a
clinical-stage, vertically integrated, leading CellTech
bio-developer dedicated to advancing and empowering innovative,
transformative immune effector cell therapy, exosome technology, as
well as COVID-19 related diagnostics and therapeutics. Avalon also
provides strategic advisory and outsourcing services to facilitate
and enhance its clients' growth and development, as well as
competitiveness in healthcare and CellTech industry markets.
Through its subsidiary structure with unique integration of
verticals from innovative R&D to automated bioproduction and
accelerated clinical development, Avalon is establishing a leading
role in the fields of cellular immunotherapy (including CAR-T/NK),
exosome technology (ACTEX™), and regenerative therapeutics. For
more information about Avalon GloboCare, please visit
www.avalon-globocare.com.
For the latest updates on Avalon GloboCare's
developments, please follow our twitter at @avalongc_avco
Contact Information: Avalon GloboCare Corp.4400 Route 9, Suite
3100Freehold, NJ 07728PR@Avalon-GloboCare.com
Investor Relations:Crescendo Communications, LLCTel: (212)
671-1020 Ext. 304avco@crescendo-ir.com
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Apr 2023 to Apr 2024